KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) Return on Invested Capital (2016 - 2023)

Historic Return on Invested Capital for Gsk (GSK) over the last 11 years, with Q4 2023 value amounting to 0.38%.

  • Gsk's Return on Invested Capital changed N/A to 0.38% in Q4 2023 from the same period last year, while for Dec 2023 it was 0.38%, marking a year-over-year change of. This contributed to the annual value of 0.07% for FY2024, which is 800.0% down from last year.
  • Per Gsk's latest filing, its Return on Invested Capital stood at 0.38% for Q4 2023.
  • Gsk's Return on Invested Capital's 5-year high stood at 4.65% during Q3 2019, with a 5-year trough of 0.38% in Q4 2023.
  • Its 3-year average for Return on Invested Capital is 1.71%, with a median of 0.81% in 2019.
  • Over the last 5 years, Gsk's Return on Invested Capital had its largest YoY gain of 14800bps in 2019, and its largest YoY loss of -2200bps in 2019.
  • Quarter analysis of 3 years shows Gsk's Return on Invested Capital stood at 0.73% in 2019, then rose by 20bps to 0.88% in 2021, then plummeted by -57bps to 0.38% in 2023.
  • Its last three reported values are 0.38% in Q4 2023, 0.88% for Q1 2021, and 0.73% during Q4 2019.